Cargando…
Hypertension and diabetes mellitus are associated with high FIB-4 index in a health checkup examination cohort without known liver disease
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is usually asymptomatic and lacks a specific biomarker; therefore, many individuals might remain undiagnosed even with advanced liver fibrosis. The aim of this study was to clarify the prevalence and clinical features of subjects with a high risk...
Autores principales: | Sato, Shunsuke, Kawai, Hidehiko, Sato, Sho, Iwasaki, Hirohiko, Omori, Masashi, Kita, Yuji, Ikeda, Yuji, Awatsu, Takahito, Murata, Ayato, Taniguchi, Gentaro, Shimada, Yuji, Genda, Takuya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677657/ https://www.ncbi.nlm.nih.gov/pubmed/36411436 http://dx.doi.org/10.1186/s12876-022-02575-5 |
Ejemplares similares
-
Post‐treatment serum Wisteria floribunda agglutinin‐positive mac‐2‐binding protein level is a useful predictor of hepatocellular carcinoma development after hepatitis C virus eradication
por: Sato, Shunsuke, et al.
Publicado: (2021) -
Hepatitis B Surface Antigen Decline during Sofosbuvir and Ribavirin Therapy in Hepatitis B Inactive Carriers Who Were Co-infected with Hepatitis C
por: Sato, Shunsuke, et al.
Publicado: (2021) -
Eosinophilic Gastroenteritis in an Ulcerative Colitis Patient During Treatment with Tumor Necrosis Factor-alpha Antagonist
por: Hayashida, Sho, et al.
Publicado: (2020) -
Comparison of the Degree of Gastric Mucosal Injury between Patients Who Are Receiving Dual Antiplatelet Therapy or Single Antiplatelet Therapy
por: Shimada, Yuji, et al.
Publicado: (2022) -
On-treatment Serum Mac-2 Binding Protein Glycosylation Isomer (M2BPGi) Level and Risk of Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B during Nucleot(s)ide Analogue Therapy
por: Murata, Ayato, et al.
Publicado: (2020)